Ramin Ramezani

Dr. Ramin Ramezani

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in Sensors
Verified
Journal Article
Open access
PDF file
Ramin RamezaniRamin Ramezani
Ramin Ramezani
MCMinh Quang Cao
Minh Quang Cao
AEArjun Earthperson
Arjun Earthperson
ANArash Naeim
Arash Naeim
Wearable devices and fitness trackers have gained popularity in healthcare and telemedicine as tools to reduce hospitalization costs, improve personalized health management, and monitor patients in remote areas. Smartwatches, particularly, offer continuous monitoring capabilities through step counting, heart rate tracking, and activity monitoring. However, despite being recognized as an emerging technology, the adoption of smartwatches in patient monitoring systems is still at an early stage, with limited studies delving beyond their feasibility. Developing healthcare applications for smartwatches faces challenges such as short battery life, wearable comfort, patient compliance, termination of non-native applications, user interaction difficulties, small touch screens, personalized sensor configuration, and connectivity with other devices. This paper presents a case study on designing an Android smartwatch application for remote monitoring of geriatric patients. It highlights obstacles encountered during app development and offers insights into design decisions and implementation details. The aim is to assist programmers in developing more efficient healthcare applications for wearable systems.

10 July 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
Ramin RamezaniRamin Ramezani
Ramin Ramezani
WZWenhao Zhang
Wenhao Zhang
ZXZhuoer Xie
Zhuoer Xie
JSJohn Shen
John Shen
DEDavid Elashoff
David Elashoff
ANArash Naeim
Arash Naeim
Background: Health care, in recent years, has made great leaps in integrating wireless technology into traditional models of care. The availability of ubiquitous devices such as wearable sensors has enabled researchers to collect voluminous datasets and harness them in a wide range of health care topics. One of the goals of using on-body wearable sensors has been to study and analyze human activity and functional patterns, thereby predicting harmful outcomes such as falls. It can also be used to track precise individual movements to form personalized behavioral patterns, to standardize the concept of frailty, well-being/independence, etc. Most wearable devices such as activity trackers and smartwatches are equipped with low-cost embedded sensors that can provide users with health statistics. In addition to wearable devices, Bluetooth low-energy sensors known as BLE beacons have gained traction among researchers in ambient intelligence domain. The low cost and durability of newer versions have made BLE beacons feasible gadgets to yield indoor localization data, an adjunct feature in human activity recognition. In the studies by Moatamed et al and the patent application by Ramezani et al, we introduced a generic framework (Sensing At-Risk Population) that draws on the classification of human movements using a 3-axial accelerometer and extracting indoor localization using BLE beacons, in concert. Objective: The study aimed to examine the ability of combination of physical activity and indoor location features, extracted at baseline, on a cohort of 154 rehabilitation-dwelling patients to discriminate between subacute care patients who are re-admitted to the hospital versus the patients who are able to stay in a community setting. Methods: We analyzed physical activity sensor features to assess activity time and intensity. We also analyzed activities with regard to indoor localization. Chi-square and Kruskal-Wallis tests were used to compare demographic variables and sensor feature variables in outcome groups. Random forests were used to build predictive models based on the most significant features. Results: Standing time percentage (P<.001, d=1.51), laying down time percentage (P<.001, d=1.35), resident room energy intensity (P<.001, d=1.25), resident bed energy intensity (P<.001, d=1.23), and energy percentage of active state (P=.001, d=1.24) are the 5 most statistically significant features in distinguishing outcome groups at baseline. The energy intensity of the resident room (P<.001, d=1.25) was achieved by capturing indoor localization information. Random forests revealed that the energy intensity of the resident room, as a standalone attribute, is the most sensitive parameter in the identification of outcome groups (area under the curve=0.84). Conclusions: This study demonstrates that a combination of indoor localization and physical activity tracking produces a series of features at baseline, a subset of which can better distinguish between at-risk patients that can gain independence versus the patients that are rehospitalized.

3 February 2020 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
JMJ. Murphy
J. Murphy
TUT. Uttamlal
T. Uttamlal
KSKelly Ann Schmidtke
Kelly Ann Schmidtke
IVI. Vlaev
I. Vlaev
DTD. Taylor
D. Taylor
Alexandra BlakemoreAlexandra Blakemore
Alexandra Blakemore
Background: Within the United Kingdom’s National Health System (NHS), patients suffering from obesity may be provided with bariatric surgery. After receiving surgery many of these patients require further support to continue to lose more weight or to maintain a healthy weight. Remotely monitoring such patients’ physical activity and other health-related variables could provide healthworkers with a more ‘ecologically valid’ picture of these patients’ behaviours to then provide more personalised support. The current study assesses the feasibility of two smartphone apps to do so. In addition, the study looks at the barriers and facilitators patients experience to using these apps effectively. Methods: Participants with a BMI > 35 kg/m2 being considered for and who had previously undergone bariatric surgery were recruited. Participants were asked to install two mobile phone apps. The ‘Moves’ app automatically tracked participants’ physical activity and the ‘WLCompanion’ app prompted participants to set goals and input other health-related information. Then, to learn about participants’ facilitators and barriers to using the apps, some participants were asked to complete a survey informed by the Theoretical Domains Framework. The data were analysed using regressions and descriptive statistics. Results: Of the 494 participants originally enrolled, 274 participants data were included in the analyses about their activity pre- and/or post-bariatric surgery (ages 18–65, M = 44.02, SD ± 11.29). Further analyses were performed on those 36 participants whose activity was tracked both pre- and post-surgery. Participants’ activity levels pre- and post-surgery did not differ. In addition, 54 participants’ survey responses suggested that the main facilitator to their continued use of the Moves app was its automatic nature, and the main barrier was its battery drain. Conclusions: The current study tracked physical activity in patients considered for and who had previously undergone bariatric surgery. The results should be interpreted with caution because of the small number of participants whose data meet the inclusion criteria and the barriers participants encountered to using the apps. Future studies should take note of the barriers to develop more user-friendly apps. Trial registration: ClinicalTrials.gov- NCT01365416 on the 3rd of June 2011.

8 September 2022 in Annals of Surgery
Verified
Journal Article
Closed access
AVArjun Verma
Arjun Verma
JHJoseph Hadaya
Joseph Hadaya
SRShannon Richardson
Shannon Richardson
AVAmulya Bs Vadlakonda
Amulya Bs Vadlakonda
Ramin RamezaniRamin Ramezani
Ramin Ramezani
PBPeyman Benharash
Peyman Benharash
Objective: To characterize the relationship between institutional robotic-assisted pulmonary lobectomy volume and hospitalization costs. Background: The high cost of robotic-assisted thoracoscopic surgery (RATS) is among several drivers of hesitation among nonadopters. Studies examining the impact of institutional experience on costs of RATS lobectomy are lacking. Methods: Adults undergoing RATS lobectomy for primary lung cancers were identified from the 2016 to 2018 Nationwide Readmissions Database. A multivariable regression to model hospitalization costs was developed with the inclusion of hospital RATS lobectomy volume as restricted cubic splines. The volume corresponding to the inflection point of the spline was used to categorize hospitals as high- (HVH) or low-volume (LVH). We subsequently examined the association of HVH status with adverse events, length of stay, costs, and 30-day, nonelective readmissions. Results: An estimated 14,756 patients underwent RATS lobectomy during the study period, with median cost of $23,000. Upon adjustment for patient and operative characteristics, hospital RATS volume was inversely associated with costs. Although only 17.2% of centers were defined as HVH, 51.7% of patients were managed at these centers. Patients at HVH and LVH had similar age, sex, and distribution of comorbidities. Notably, patients at HVH had decreased risk-adjusted odds of adverse events (adjusted odds ratio: 0.62, P<0.001), as well as significantly reduced length of stay (−0.8 d, P<0.001) and costs (−$3900, P<0.001). Conclusions: Increasing hospital RATS lobectomy volume was associated with reduced hospitalization costs. Our findings suggest the presence of streamlined care pathways at high-volume centers, which influence costs of care.

11 March 2025 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
Ramin RamezaniRamin Ramezani
Ramin Ramezani
SISaam Iranmanesh
Saam Iranmanesh
ANArash Naeim
Arash Naeim
PBPeyman Benharash\R\N
Peyman Benharash\R\N
A comprehensive understanding of patients' functional and mental well-being is crucial, particularly for individuals with high-risk conditions. Continuous, long-term data collection facilitates improved risk stratification, personalized treatment selection, and early detection of adverse events. Real-time monitoring enables timely interventions, reducing resource utilization while enhancing quality of life. As healthcare systems transition toward precision and accountable care, achieving these goals necessitates innovative, cost-eBicient, and scalable patient monitoring technologies.Recent advancements in mobile applications, wearable devices, and physiological sensors have enabled continuous digital monitoring of a wide range of physiological and psychological parameters, often referred to as "digital breadcrumbs." This editorial collection explores how these technologies enhance clinical decision-making, the challenges in data analysis, and methods to bridge the gap from research to real-world implementation with the goal that contributions to this call will further facilitate the "translation" of clinical use of technology from "bench to bedside".The COVID-19 pandemic significantly accelerated the adoption of telemedicine and remote patient monitoring. The study [1] examined a healthcare provider's experience in launching a COVID-19 Remote Patient Monitoring (CRPM) program and found that leadership engagement was the most frequently cited key factor for successful implementation.The pandemic is believed to have at least partly contributed to the global rise in mental health disorders, with the CDC estimating that one in three adults in the U.S. experiences significant anxiety or depression symptoms. While ketamine has emerged as a major innovation in psychopharmacology in recent years, the FDA approved a specific form of ketamine, Spravato, for use in Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with suicidal ideation. While these drugs show promise, a substantial degree of patient monitoring is critical for treatments that alter consciousness. The study [2] explored a proof-of-concept system, the MindMed Session Monitoring System, which passively collects physiological data such as activity levels, steps, audio, and heart rate from mobile and wearable devices. The study assessed data quality and feasibility in 24 participants undergoing Spravato (ketamine) treatment, providing insights into the potential for real-time monitoring applications in mental health care.With the rapid increase in the geriatric population (65+) globally, including the U.S., alongside the staggering number of approximately 5 million patients in the U.S. living with dementia, the importance of remote patient monitoring has become increasingly evident. Monitoring Activities of Daily Living (ADLs) through such technologies represents one of their most suitable applications; however, certain limitations persist. These include challenges in capturing detailed intra-and inter-individual variabilities, as well as concerns regarding subjectivity, reliability, reproducibility, and sensitivity to changes in behavior.The paper [3] presents pilot data on an AI-based clinical decision support tool that leverages computer vision to monitor older adults in their home environments. The authors express optimism that future advancements in monitoring technologies will enable the accurate assessment of ADLs with minimal representative samples, thereby improving behavioral analysis models and enhancing their ability to determine functional performance in various environments with greater accuracy and objectivity.Paper [4] introduces a novel method for automated biomarker identification and quantification using standard RGB video capture for monitoring low-risk patients, such as those with osteoarthritis (OA). By leveraging a camera-based approach, this method facilitates the monitoring of treatment effectiveness and disease progression, thereby reducing the burden on healthcare providers, particularly when routine in-person visits for low-risk patients may be challenging to sustain. The study collected clinically relevant motion data from 20 patients and proposed a technique that generates 3D human shape and pose from 2D video data through adversarial training in a deep neural network with a self-attention mechanism designed to encode both spatial and temporal information. In a clinical study on a small population of patients with knee pain, the extracted biomarkers demonstrated statistical significance in evaluating treatment outcomes, tracking rehabilitation progress, and monitoring disease progression. Key biomarkers identified include the cumulative acceleration of elbow flexion/extension during a sit-to-stand task, as well as the smoothness of knee and elbow flexion/extension during both squat and sit-to-stand movements.Paper [5] examines the experiences, barriers, and expectations associated with deploying remote patient monitoring (RPM) systems for intensive care unit (ICU) nurses in a university hospital setting. The study conducted interviews with ICU nurses to assess their perspectives on the use of technologies such as vital signs monitors, electrocardiogram (ECG) machines, and pulse oximeters, which facilitate continuous monitoring of patients' physiological indicators.Nurses emphasized the importance of user-friendly interfaces and clear visualization in enhancing the efficiency of these systems. However, a key concern identified was poor alarm handling, which was recognized as a potential patient safety hazard. The study underscores the critical need for high accessibility, wireless, noninvasive, and interoperable RPM systems, which would likely benefit from the expansion and deployment of cloud-based platforms to improve integration and usability in clinical workflows.Among the wide range of remote patient monitoring (RPM) applications, various gadgets and devices have been...

6 November 2024 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
MCMinh Cao
Minh Cao
Ramin RamezaniRamin Ramezani
Ramin Ramezani
VKVivek Kumar Katakwar
Vivek Kumar Katakwar
WZWenhao Zhang
Wenhao Zhang
DBDheeraj Boda
Dheeraj Boda
ANArash Naeim
Arash Naeim
Wearable sensor devices for continuous patient monitoring produce a large volume of data, necessitating scalable infrastructures for efficient data processing, management and security, especially concerning Patient Health Information (PHI). Adherence to the Health Insurance Portability and Accountability Act (HIPAA), a legislation that mandates developers and healthcare providers to uphold a set of standards for safeguarding patients’ health information and privacy, further complicates the development of remote patient monitoring within healthcare ecosystems. This paper presents an Internet of Things (IoT) architecture designed for the healthcare sector, utilizing commercial cloud platforms like Microsoft Azure and Amazon Web Services (AWS) to develop HIPAA-compliant health monitoring systems. By leveraging cloud functionalities such as scalability, security, and load balancing, the architecture simplifies the creation of infrastructures adhering to HIPAA standards. The study includes a cost analysis of Azure and AWS infrastructures and evaluates data processing speeds and database query latencies, offering insights into their performance for healthcare applications.